In 2023, hospital discharges for malignant neoplasm of the bladder in France stood at XX.X per hundred thousand persons. The forecast data from 2024 to 2028 reveals a consistent upward trend, with values increasing from 76.3 to 78.7 per hundred thousand persons. Analyzing year-on-year variations, there is a steady annual growth of approximately 0.8%. The cumulative annual growth rate (CAGR) over this five-year period is approximately 0.8% per year, indicating a modest yet consistent increase in hospital discharges.

Future trends to watch for:

Advancements in medical treatments and early detection methods that could impact discharge rates.
Changes in healthcare policies or demographic shifts in France that may influence these forecasts.
Potential impacts of public health initiatives aimed at bladder cancer prevention and management.